Invesco’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $82.8M | Sell |
362,109
-223,985
| -38% | -$50.2M | 0.01% | 889 |
|
|
2025
Q4 | $125M | Sell |
586,094
-331,809
| -36% | -$68.5M | 0.02% | 772 |
|
|
2025
Q3 | $182M | Sell |
917,903
-29,323
| -3% | -$5.47M | 0.03% | 699 |
|
|
2025
Q2 | $163M | Sell |
947,226
-251,252
| -21% | -$40.9M | 0.03% | 699 |
|
|
2025
Q1 | $187M | Buy |
1,198,478
+42,465
| +4% | +$6.07M | 0.04% | 638 |
|
|
2024
Q4 | $159M | Sell |
1,156,013
-6,232
| -0.5% | -$819K | 0.03% | 693 |
|
|
2024
Q3 | $174M | Buy |
1,162,245
+55,796
| +5% | +$7.54M | 0.03% | 657 |
|
|
2024
Q2 | $151M | Buy |
1,106,449
+141,786
| +15% | +$19.3M | 0.03% | 662 |
|
|
2024
Q1 | $146M | Buy |
964,663
+56,752
| +6% | +$8.1M | 0.03% | 687 |
|
|
2023
Q4 | $114M | Buy |
907,911
+235,785
| +35% | +$23.5M | 0.03% | 714 |
|
|
2023
Q3 | $62.9M | Buy |
672,126
+57,413
| +9% | +$5.37M | 0.02% | 866 |
|
|
2023
Q2 | $54.9M | Sell |
614,713
-31,847
| -5% | -$2.77M | 0.01% | 914 |
|
|
2023
Q1 | $69.3M | Sell |
646,560
-14,226
| -2% | -$1.63M | 0.02% | 833 |
|
|
2022
Q4 | $80.7M | Buy |
660,786
+60,763
| +10% | +$7.05M | 0.02% | 772 |
|
|
2022
Q3 | $62M | Buy |
600,023
+7,368
| +1% | +$699K | 0.02% | 827 |
|
|
2022
Q2 | $55.1M | Sell |
592,655
-424,435
| -42% | -$40M | 0.02% | 891 |
|
|
2022
Q1 | $119M | Buy |
1,017,090
+14,047
| +1% | +$1.63M | 0.03% | 703 |
|
|
2021
Q4 | $135M | Sell |
1,003,043
-24,219
| -2% | -$3.6M | 0.03% | 680 |
|
|
2021
Q3 | $164M | Sell |
1,027,262
-131,762
| -11% | -$18M | 0.04% | 600 |
|
|
2021
Q2 | $152M | Buy |
1,159,024
+424,732
| +58% | +$56.6M | 0.04% | 651 |
|
|
2021
Q1 | $94.6M | Sell |
734,292
-32,412
| -4% | -$4.93M | 0.03% | 834 |
|
|
2020
Q4 | $128M | Sell |
766,704
-935
| -0.1% | -$155K | 0.04% | 619 |
|
|
2020
Q3 | $118M | Buy |
767,639
+164,834
| +27% | +$23.7M | 0.04% | 570 |
|
|
2020
Q2 | $89.2M | Buy |
602,805
+8,384
| +1% | +$1.15M | 0.03% | 640 |
|
|
2020
Q1 | $66.9M | Buy |
594,421
+1,098
| +0.2% | +$143K | 0.03% | 669 |
|
|
2019
Q4 | $82.5M | Sell |
593,323
-425,269
| -42% | -$47.2M | 0.03% | 761 |
|
|
2019
Q3 | $98.1M | Buy |
1,018,592
+4,246
| +0.4% | +$474K | 0.03% | 667 |
|
|
2019
Q2 | $117M | Buy |
1,014,346
+924,169
| +1,025% | +$111M | 0.03% | 616 |
|
|
2019
Q1 | $10.6M | Sell |
90,177
-53,962
| -37% | -$4.73M | ﹤0.01% | 1534 |
|
|
2018
Q4 | $9.03M | Sell |
144,139
-817
| -0.6% | -$51.3K | ﹤0.01% | 1589 |
|
|
2018
Q3 | $10.3M | Sell |
144,956
-7,350
| -5% | -$506K | ﹤0.01% | 1681 |
|
|
2018
Q2 | $10.1M | Buy |
+152,306
| New | +$10M | ﹤0.01% | 1653 |
|
Other funds holding ASND
RCM
ACA
